Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut microbiota dysbiosis restoration is a therapeutic strategy aimed at reestablishing the healthy balance, diversity, and function of the gastrointestinal microbial community when disrupted. Restoration strategies include the use of probiotics, prebiotics, synbiotics, dietary modifications, FMT, and emerging biotherapeutics. These interventions are designed to overcome a loss of beneficial microbes, diminishing diversity, and overgrowth of potentially pathogenic species that characterize dysbiosis. Restoration is not an action at a single molecular target but is an ecological, compositional, and functional rebalancing of a complex microbial ecosystem, often with impacts on immune regulation, metabolic function, and systemic disease processes[1][2][3][6]. In summary, “gut microbiota dysbiosis restoration” should not be regarded as a molecular drug target but as a multifaceted therapeutic approach, with its interventions interacting with numerous known (and sometimes unknown) molecular and cellular pathways.
Restoration of microbial diversity by introducing beneficial microorganisms (probiotics, FMT); Promotion of beneficial microbial growth through specific dietary components (prebiotics); Competition with or inhibition of pathogenic microbes; Modulation of immune system by microbial metabolites (e.g., short-chain fatty acids); Modulation of intestinal barrier function
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota dysbiosis restoration.